Related Experiment Videos
[Antibiotic therapy in the surgical treatment of suppurative cholangitis]
Vestnik Khirurgii Imeni I. I. Grekova
|July 1, 1985
Abstract:
The pathogenic agents of purulent cholangitis are known to be the conditionally pathogenic mainly gram-negative bacteria of the intestinal group. Kanamycin, monomycin, furazolidon should be used. The antibiotic treatment should be corrected according to data of inoculations of blood taken during the first days of staying in the hospital, then to data of inoculations of bile taken both during operation and at the 3d-4th postoperative days.
Insights
Purulent cholangitis is caused by gram-negative intestinal bacteria. Effective treatment involves antibiotics like kanamycin, adjusted based on blood and bile cultures for optimal patient outcomes.
Area of Science:
- Microbiology
- Infectious Diseases
- Pharmacology
Context:
- Purulent cholangitis is a severe biliary tract infection.
- Gram-negative bacteria from the intestinal group are primary causative agents.
Purpose:
- To outline appropriate antibiotic selection and treatment adjustment strategies for purulent cholangitis.
- To emphasize the importance of microbiological data in guiding therapy.
Summary:
- The primary pathogens in purulent cholangitis are typically gram-negative, facultative anaerobic bacteria of the intestinal flora.
- Recommended initial antibiotics include kanamycin, monomycin, and furazolidone.
- Treatment regimens must be dynamically adjusted based on blood cultures obtained early in hospitalization and bile cultures from intraoperative and postoperative periods (3rd-4th day).
Impact:
- This approach aims to improve treatment efficacy by tailoring antibiotic therapy to specific microbial profiles.
- Optimized antibiotic selection and timing can lead to better patient recovery and reduced complications from purulent cholangitis.